Cargando…
A case report of toxic epidermal necrolysis associated with AZD-9291
Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are a strain of small molecule inhibitors mainly used to treat the metastatic non-small cell lung cancer. Their predominant adverse effect is skin toxicity, usually manifested as acneiform rash, skin fissure, xerosis, and parony...
Autores principales: | Wang, Jie, Cheng, XianYe, Lu, Yan, Zhou, BingRong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047856/ https://www.ncbi.nlm.nih.gov/pubmed/30034220 http://dx.doi.org/10.2147/DDDT.S168248 |
Ejemplares similares
-
Successful treatment after toxic epidermal necrolysis induced by AZD-9291 in a patient with non-small cell lung cancer: A case report
por: Li, Wen, et al.
Publicado: (2021) -
Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
por: Liu, Wen-Yu, et al.
Publicado: (2022) -
Heterogeneity‐based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case report
por: Liu, Yutao, et al.
Publicado: (2018) -
Transformation to small-cell carcinoma as an acquired resistance mechanism to AZD9291: A case report
por: Li, Lin, et al.
Publicado: (2017) -
AZD9291-induced Acute Interstitial Lung Disease
por: Nie, Ke-Ke, et al.
Publicado: (2016)